Related Experiment Videos
Can FDA seek restitution or disgorgement?
Jeffrey N Gibbs1, John R Fleder
1Hyman, Phelps & McNamara, P.C., Washington, D.C., USA.
Food and Drug Law Journal
|July 18, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Litigating the legality of compounding: the medical center pharmacy case.
International journal of pharmaceutical compounding·2013
Regulating molecular diagnostic assays: developing a new regulatory structure for a new technology.
Expert review of molecular diagnostics·2011
When the Alpha is the Omega: P-Values, "Substantial Evidence," and the 0.05 Standard at FDA.
Food and drug law journal·2018
FDA's Flexibility in Subpart H Approvals: Assessing Quantum of Effectiveness Evidence.
Food and drug law journal·2018
Genetically Modified Food Labeling in China: In Pursuit of a Rational Path.
Food and drug law journal·2018
Communicating Tobacco Product Information to the Public.
Food and drug law journal·2018
A Recipe for Justice: Support for a Federal Food Justice Interagency Working Group.
Food and drug law journal·2017
Re-Framing Biotechnology Regulation.
Food and drug law journal·2017
Effect of Second Sling Type on the Success of Repeat Procedures.
Urogynecology (Philadelphia, Pa.)·2026
Association Between Leukocytospermia and Varicocele in Patients With Infertility.
American journal of reproductive immunology (New York, N.Y. : 1989)·2026